Display options
Cite
Chang KJ, Cheng CK, Peng CH. Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization. Taiwan J Ophthalmol. 2016;6(3):136-140doi: 10.1016/j.tjo.2016.05.007.
Chang, K. J., Cheng, C. K., & Peng, C. H. (2016). Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization. Taiwan journal of ophthalmology, 6(3), 136-140. https://doi.org/10.1016/j.tjo.2016.05.007
Chang, Kuei-Jung, et al. "Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization." Taiwan journal of ophthalmology vol. 6,3 (2016): 136-140. doi: https://doi.org/10.1016/j.tjo.2016.05.007
Chang KJ, Cheng CK, Peng CH. Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization. Taiwan J Ophthalmol. 2016 Jul-Sep;6(3):136-140. doi: 10.1016/j.tjo.2016.05.007. Epub 2016 Jun 24. PMID: 29018729; PMCID: PMC5525620.
Copy Download .nbib Format: NLM
Share it on

Taiwan J Ophthalmol. 2016 Jul-Sep;6(3):136-140. doi: 10.1016/j.tjo.2016.05.007. Epub 2016 Jun 24.

Clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization.

Taiwan journal of ophthalmology

Kuei-Jung Chang, Cheng-Kuo Cheng, Chi-Hsien Peng

Affiliations

  1. Department of Ophthalmology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
  2. School of Medicine, Catholic Fu-Jen University, New Taipei City, Taiwan.
  3. School of Medicine, National Taiwan University, Taipei, Taiwan.

PMID: 29018729 PMCID: PMC5525620 DOI: 10.1016/j.tjo.2016.05.007

Abstract

BACKGROUND/PURPOSE: This study aims to evaluate the clinical characteristics and visual outcome of macular hemorrhage in pathological myopia with or without choroidal neovascularization.

METHODS: We conducted a retrospective study of 55 patients with macular coin hemorrhage who were followed for at least 3 months from January 1997 to December 2013 at Shin Kong Wu Ho-Su Memorial Hospital (Taipei, Taiwan). All patients were evaluated using fluorescein angiography and optical coherence tomography for the detection of choroidal neovascularization (CNV). We also recorded clinical characteristics such as age, sex, refractory error, and myopic fundus, to determine the relationship between CNV and non-CNV associated macular hemorrhage.

RESULTS: A total of 55 patients (30 females, 54.55%) were reviewed. The mean age was 39.7 years old. The CNV group was found to be significantly older than the non-CNV group (

CONCLUSION: Age significantly correlated to the CNV formation in high myopia with macular hemorrhage. Favorable visual outcomes were found in pathological myopic macular hemorrhage either in the anti-VEGF treated, CNV associated group or in the untreated, non-CNV associated group.

Keywords: Fuchs’ spot; anti-VEGF; choroidal neovascularization; macular hemorrhage; pathologic myopia

Conflict of interest statement

Conflicts of interest: All contributing authors declare no conflicts of interest.

References

  1. Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2486-94 - PubMed
  2. Am J Ophthalmol. 1975 Mar;79(3):386-92 - PubMed
  3. Ophthalmology. 2001 May;108(5):841-52 - PubMed
  4. Ophthalmology. 2003 Jul;110(7):1297-305 - PubMed
  5. Retina. 1992;12(2):127-33 - PubMed
  6. Yan Ke Xue Bao. 2004 Mar;20(1):57-62 - PubMed
  7. Graefes Arch Clin Exp Ophthalmol. 1990;228(4):277-80 - PubMed
  8. Am J Ophthalmol. 2009 Jan;147(1):84-93.e1 - PubMed
  9. Optom Vis Sci. 2009 Jan;86(1):40-4 - PubMed
  10. Am J Ophthalmol. 2009 May;147(5):811-5 - PubMed
  11. Am J Ophthalmol. 2009 Sep;148(3):445-50 - PubMed
  12. Retina. 2009 Sep;29(8):1062-6 - PubMed
  13. Arch Ophthalmol. 2009 Dec;127(12):1632-9 - PubMed
  14. Retina. 2010 Mar;30(3):418-24 - PubMed
  15. Am J Ophthalmol. 2010 Mar;149(3):458-64.e1 - PubMed
  16. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3721-5 - PubMed
  17. Am J Ophthalmol. 2010 Sep;150(3):325-329.e1 - PubMed
  18. Ophthalmologica. 2012;227(1):39-44 - PubMed
  19. Invest Ophthalmol Vis Sci. 2011 Dec 20;52(13):9555-60 - PubMed
  20. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):1-7 - PubMed
  21. Eye (Lond). 2012 Jul;26(7):1004-11 - PubMed
  22. Invest Ophthalmol Vis Sci. 2012 Aug 15;53(9):5579-83 - PubMed
  23. Am J Ophthalmol. 2013 Feb;155(2):314-319.e1 - PubMed
  24. Invest Ophthalmol Vis Sci. 2012 Nov 01;53(12):7504-9 - PubMed
  25. Am J Ophthalmol. 2013 May;155(5):913-9 - PubMed
  26. Ophthalmology. 2013 Jul;120(7):1482-91 - PubMed
  27. Ophthalmology. 2013 Sep;120(9):1909-14 - PubMed
  28. Br J Ophthalmol. 2013 Nov;97(11):1447-50 - PubMed
  29. Eye (Lond). 2015 Apr;29(4):519-24 - PubMed
  30. Taiwan J Ophthalmol. 2015 Apr-Jun;5(2):76-84 - PubMed
  31. Am J Ophthalmol. 1988 Sep 15;106(3):282-5 - PubMed
  32. Ophthalmology. 1984 Dec;91(12):1573-81 - PubMed
  33. Retina. 1996;16(3):196-202 - PubMed
  34. Am J Ophthalmol. 1996 Oct;122(4):486-93 - PubMed
  35. Retina. 1996;16(1):29-37 - PubMed
  36. Invest Ophthalmol Vis Sci. 1997 Feb;38(2):334-40 - PubMed
  37. Eur J Ophthalmol. 1997 Oct-Dec;7(4):307-16 - PubMed

Publication Types